Cell Therapy News Volume 22.19 | May 31 2021

    0
    64







    2021-05-31 | CTN 22.19


    Cell Therapy News by STEMCELL Technologies
    Vol. 22.19 – 31 May, 2021
    TOP STORY

    Development of CAR T-cell Lymphoma in Two of Ten Patients Effectively Treated with piggyBac Modified CD19 CAR T-cells

    The authors demonstrated the feasibility of generating CD19-specific CAR19 T-cells from HLA-matched donors of sibling allogeneic hematopoietic stem cell transplant patients via a simple and inexpensive method using the piggyBac transposon.
    [Blood]

    Abstract

    Register for the Virtual World Stem Cell Summit and Regenerative Medicine Essentials Course
    PUBLICATIONSRanked by the impact factor of the journal

    Injectable Self-Healing Hydrogel via Biological Environment-Adaptive Supramolecular Assembly for Gastric Perforation Healing

    Scientists reported an example of injectable self-healing hydrogel based on gastric environment-adaptive supramolecular assembly, and explored its application for gastric perforation healing.
    [ACS Nano]

    AbstractGraphical Abstract

    An Oncolytic Virus Expressing IL-15/IL-15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma

    Investigators generated a herpes simplex 1-based oncolytic viruses expressing human IL-15/IL-15Rα sushi domain fusion protein, as well as off-the-shelf EGFR-CAR natural killer (NK) cells, and studied their monotherapy and combination efficacy in vitro and in multiple glioblastoma mouse models.
    [Cancer Research]

    Abstract

    Prolonged Suppression of Butyrate Producing Bacteria Is Associated with Acute Gastrointestinal Graft-versus-Host Disease and Transplant Related Mortality after Allogeneic Stem Cell Transplantation

    Scientists examined the abundance and butyrogenic capacity of butyrate producing bacteria in 28 healthy donors and 201 patients after allogeneic stem cell transplantation.
    [Clinical infectious Diseases]

    Abstract

    Inhibition of Nuclear Factor (Erythroid-Derived 2)-like 2 Promotes Hepatic Progenitor Cell Activation and Differentiation

    Researchers analyzed the oxidative damage in models of liver injury characterized by biliary epithelial cells/hepatic progenitor cells (HPCs) activation and defined the impact of redox balance perturbation on HPC fate.
    [NPJ Regenerative Medicine]

    Full Article

    Adropin-Based Dual Treatment Enhances the Therapeutic Potential of Mesenchymal Stem Cells in Rat Myocardial Infarction

    Adropin in vitro reduced hydrogen peroxide-induced apoptosis in rat bone marrow mesenchymal stem cells (MSCs) and improved MSCs survival with increased phosphorylation of Akt and extracellular regulated protein kinases.
    [Cell Death & Disease]

    Full Article

    Upregulation of Apol8 by Epothilone D Facilitates the Neuronal Relay of Transplanted NSCs in Spinal Cord Injury

    Epothilone D could promote the neuronal differentiation of neural stem cells (NSCs) by upregulating Apol8, which might provide a promising therapeutic target for spinal cord injury repair.
    [Stem Cell Research & Therapy]

    Full Article

    Withaferin A Inhibits Lymphocyte Proliferation, Dendritic Cell Maturation In Vitro and Prolongs Islet Allograft Survival

    The authors investigated the immunosuppressive and immunomodulation abilities of Withaferin A and its effect on long-term islet allograft survival.
    [Scientific Reports]

    Full Article

    Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplant: A New Paradigm of Treatment in Wolman Disease

    Investigators described five Wolman disease patients diagnosed in infancy that were treated at Royal Manchester Children’s Hospital receiving enzyme replacement therapy with dietary substrate reduction then hematopoietic stem cell transplant — multimodal therapy.
    [Orphanet Journal of Rare Diseases]

    Full Article

    Optimal Conditions for Graft Survival and Reinnervation of Denervated Muscles after Embryonic Motoneuron Transplantation into Peripheral Nerves Undergoing Wallerian Degeneration

    The authors investigated whether functional reinnervation of denervated muscle could be achieved by early or delayed transplantation after denervation.
    [Journal of Tissue Engineering and Regenerative Medicine]

    Abstract


    Watch this webinar to learn about the role of microglia in mechanisms of immune activation to Alzheimer's pathology.
    REVIEWS

    Is There a Place for CAR-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?

    Scientists introduce CAR-T cell technology, describe the meaningful achievements of CAR-T cells observed in onco-hematology and discuss preliminary data obtained with CAR-T cells and their derivative constructions in experimental models of autoimmune diseases.
    [Arthritis & Rheumatology]

    Abstract

    The Antigen-Binding Moiety in the Driver’s Seat of CARs

    The authors present the history of CAR-T cell therapy, and then expand on various developments in the CAR ectodomain. They discuss different formats, each with their own advantages and disadvantages, as well as the developments in affinity tuning, avidity effects, epitope location, and influence of the extracellular spacer.
    [Medicinal Research Reviews]

    Full Article

    INDUSTRY AND POLICY NEWS

    GlycoMimetics Announces Investigator-Sponsored Phase II Clinical Trial Evaluating Uproleselan for Prevention of Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplantation

    GlycoMimetics, Inc. announced that clinicians at Washington University School of Medicine in St. Louis have dosed the first patient in an investigator-sponsored trial evaluating uproleselan as a prophylactic agent to reduce gastrointestinal toxicities associated with high-dose melphalan in autologous hematopoietic cell transplantation for multiple myeloma.
    [GlycoMimetics, Inc.]

    Press Release

    Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase II Pivotal Clinical Trial of COVI-MSCâ„¢ in Hospitalized COVID-19 Patients with Acute Respiratory Distress Syndrome

    Sorrento Therapeutics, Inc. announced receipt of clearance from the ANVISA to proceed with a Phase II Pivotal clinical trial of COVI-MSCâ„¢, an injectable infusion of MSCs, for the treatment of hospitalized COVID-19 patients suffering from acute respiratory distress syndrome.
    [Sorrento Therapeutics, Inc.]

    Press Release

    FEATURED EVENT

    Epigenetic Therapeutic Target Summit

    July 13 – 15, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Gene Therapy

    Cedars Sinai – Los Angeles, California, United States

    Postdoctoral Associate – Immunotherapy, Genomic Instability, Anti-Tumor Immunity

    Baylor College of Medicine – Houston, Texas, United States

    Senior Researcher – Clinical Genome Editing

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Assistant, Associate, Full Professor – Stem Cell Biology and Regenerative/Restorative Medicine

    Stanford University – Stanford, California, United States

    Postdoctoral Researcher Fellowships – Center for Stem Cell and Regenerative Medicine

    Zhejiang University – Zhejiang, China

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter